Global mRNA Drug Market Research Report 2025(Status and Outlook)
Report Overview
Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.
This report provides a deep insight into the global mRNA Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA Drug market in any manner.
Global mRNA Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Moderna
Pfizer
Zydus Cadila
Fosun Pharma
CureVAC
Sri Lankan Microorganisms
BioNtech
AstraZeneca
Janssen
Market Segmentation (by Type)
Preventive Vaccines
Therapeutic Vaccine
Therapeutic Drugs
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the mRNA Drug Market
- Overview of the regional outlook of the mRNA Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of mRNA Drug
1.2 Key Market Segments
1.2.1 mRNA Drug Segment by Type
1.2.2 mRNA Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL MRNA DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global mRNA Drug Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global mRNA Drug Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL MRNA DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global mRNA Drug Product Life Cycle
3.3 Global mRNA Drug Sales by Manufacturers (2020-2025)
3.4 Global mRNA Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 mRNA Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global mRNA Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers mRNA Drug Manufacturing Sites, Area Served, Product Type
3.8 mRNA Drug Market Competitive Situation and Trends
3.8.1 mRNA Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest mRNA Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MRNA DRUG INDUSTRY CHAIN ANALYSIS
4.1 mRNA Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRNA DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global mRNA Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to mRNA Drug Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL MRNA DRUG MARKET BY REGION
6.1 Global mRNA Drug Market Size by Region
6.1.1 Global mRNA Drug Market Size by Region
6.1.2 Global mRNA Drug Market Size Market Share by Region
6.2 Global mRNA Drug Sales by Region
6.2.1 Global mRNA Drug Sales by Region
6.2.2 Global mRNA Drug Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America mRNA Drug Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America mRNA Drug Market Size by Type
7.3 North America mRNA Drug Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe mRNA Drug Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe mRNA Drug Market Size by Type
8.3 Europe mRNA Drug Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific mRNA Drug Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific mRNA Drug Market Size by Type
9.3 Asia-Pacific mRNA Drug Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America mRNA Drug Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America mRNA Drug Market Size by Type
10.3 South America mRNA Drug Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa mRNA Drug Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa mRNA Drug Market Size by Type
11.3 Middle East and Africa mRNA Drug Market Size by Application
12 MRNA DRUG MARKET PRODUCTION BY REGION
12.1 Global Production of mRNA Drug by Region(2020-2025)
12.2 Global mRNA Drug Revenue Market Share by Region (2020-2025)
12.3 Global mRNA Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America mRNA Drug Production
12.4.1 North America mRNA Drug Production Growth Rate (2020-2025)
12.4.2 North America mRNA Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe mRNA Drug Production
12.5.1 Europe mRNA Drug Production Growth Rate (2020-2025)
12.5.2 Europe mRNA Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan mRNA Drug Production (2020-2025)
12.6.1 Japan mRNA Drug Production Growth Rate (2020-2025)
12.6.2 Japan mRNA Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China mRNA Drug Production (2020-2025)
12.7.1 China mRNA Drug Production Growth Rate (2020-2025)
12.7.2 China mRNA Drug Production, Revenue, Price and Gross Margin (2020-2025)
13 MRNA DRUG MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global mRNA Drug Sales Market Share by Type (2020-2033)
13.3 Global mRNA Drug Market Size Market Share by Type (2020-2033)
13.4 Global mRNA Drug Price by Type (2020-2033)
14 MRNA DRUG MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global mRNA Drug Market Sales by Application (2020-2033)
14.3 Global mRNA Drug Market Size (M USD) by Application (2020-2033)
14.4 Global mRNA Drug Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 Moderna
15.1.1 Moderna Basic Information
15.1.2 Moderna mRNA Drug Product Overview
15.1.3 Moderna mRNA Drug Product Market Performance
15.1.4 Moderna Business Overview
15.1.5 Moderna SWOT Analysis
15.1.6 Moderna Recent Developments
15.2 Pfizer
15.2.1 Pfizer Basic Information
15.2.2 Pfizer mRNA Drug Product Overview
15.2.3 Pfizer mRNA Drug Product Market Performance
15.2.4 Pfizer Business Overview
15.2.5 Pfizer SWOT Analysis
15.2.6 Pfizer Recent Developments
15.3 Zydus Cadila
15.3.1 Zydus Cadila Basic Information
15.3.2 Zydus Cadila mRNA Drug Product Overview
15.3.3 Zydus Cadila mRNA Drug Product Market Performance
15.3.4 Zydus Cadila Business Overview
15.3.5 Zydus Cadila SWOT Analysis
15.3.6 Zydus Cadila Recent Developments
15.4 Fosun Pharma
15.4.1 Fosun Pharma Basic Information
15.4.2 Fosun Pharma mRNA Drug Product Overview
15.4.3 Fosun Pharma mRNA Drug Product Market Performance
15.4.4 Fosun Pharma Business Overview
15.4.5 Fosun Pharma Recent Developments
15.5 CureVAC
15.5.1 CureVAC Basic Information
15.5.2 CureVAC mRNA Drug Product Overview
15.5.3 CureVAC mRNA Drug Product Market Performance
15.5.4 CureVAC Business Overview
15.5.5 CureVAC Recent Developments
15.6 Sri Lankan Microorganisms
15.6.1 Sri Lankan Microorganisms Basic Information
15.6.2 Sri Lankan Microorganisms mRNA Drug Product Overview
15.6.3 Sri Lankan Microorganisms mRNA Drug Product Market Performance
15.6.4 Sri Lankan Microorganisms Business Overview
15.6.5 Sri Lankan Microorganisms Recent Developments
15.7 BioNtech
15.7.1 BioNtech Basic Information
15.7.2 BioNtech mRNA Drug Product Overview
15.7.3 BioNtech mRNA Drug Product Market Performance
15.7.4 BioNtech Business Overview
15.7.5 BioNtech Recent Developments
15.8 AstraZeneca
15.8.1 AstraZeneca Basic Information
15.8.2 AstraZeneca mRNA Drug Product Overview
15.8.3 AstraZeneca mRNA Drug Product Market Performance
15.8.4 AstraZeneca Business Overview
15.8.5 AstraZeneca Recent Developments
15.9 Janssen
15.9.1 Janssen Basic Information
15.9.2 Janssen mRNA Drug Product Overview
15.9.3 Janssen mRNA Drug Product Market Performance
15.9.4 Janssen Business Overview
15.9.5 Janssen Recent Developments
16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global mRNA Drug Market Size by Type (M USD)
Table 4. Global mRNA Drug Market Size by Application (M USD)
Table 5. mRNA Drug Market Size Comparison by Region (M USD)
Table 6. Global mRNA Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global mRNA Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global mRNA Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global mRNA Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Drug as of 2024)
Table 11. Global Market mRNA Drug Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers mRNA Drug Manufacturing Sites and Area Served
Table 13. Manufacturers mRNA Drug Product Type
Table 14. Global mRNA Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. mRNA Drug Market Size Comparison by Region (M USD)
Table 26. Global mRNA Drug Market Size by Region (2020-2033) & (M USD)
Table 27. Global mRNA Drug Market Size Market Share by Region (2020-2033)
Table 28. Global mRNA Drug Sales by Region (2020-2033) & (K MT)
Table 29. Global mRNA Drug Sales Market Share by Region (2020-2033)
Table 30. North America mRNA Drug Market Size by Country (2020-2033) & (M USD)
Table 31. North America mRNA Drug Sales by Country (2020-2033) & (K MT)
Table 32. North America mRNA Drug Sales by Type (K MT)
Table 33. North America mRNA Drug Market Size by Type (M USD)
Table 34. North America mRNA Drug Sales (K MT) by Type (2020-2033)
Table 35. North America mRNA Drug Market Size (M USD) by Type (2020-2033)
Table 36. North America mRNA Drug Sales by Application (K MT)
Table 37. North America mRNA Drug Market Size by Application (M USD)
Table 38. North America mRNA Drug Sales (K MT) by Application (2020-2033)
Table 39. North America mRNA Drug Market Size (M USD) by Application (2020-2033)
Table 40. Europe mRNA Drug Market Size by Country (2020-2033) & (M USD)
Table 41. Europe mRNA Drug Sales by Country (2020-2033) & (K MT)
Table 42. Europe mRNA Drug Sales by Type (K MT)
Table 43. Europe mRNA Drug Market Size by Type (M USD)
Table 44. Europe mRNA Drug Sales (K MT) by Type (2020-2033)
Table 45. Europe mRNA Drug Market Size (M USD) by Type (2020-2033)
Table 46. Europe mRNA Drug Sales by Application (K MT)
Table 47. Europe mRNA Drug Market Size by Application (M USD)
Table 48. Europe mRNA Drug Sales (K MT) by Application (2020-2033)
Table 49. Europe mRNA Drug Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific mRNA Drug Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific mRNA Drug Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific mRNA Drug Sales by Type (K MT)
Table 53. Asia-Pacific mRNA Drug Market Size by Type (M USD)
Table 54. Asia-Pacific mRNA Drug Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific mRNA Drug Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific mRNA Drug Sales by Application (K MT)
Table 57. Asia-Pacific mRNA Drug Market Size by Application (M USD)
Table 58. Asia-Pacific mRNA Drug Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific mRNA Drug Market Size (M USD) by Application (2020-2025)
Table 60. South America mRNA Drug Market Size by Country (2020-2033) & (M USD)
Table 61. South America mRNA Drug Sales by Country (2020-2033) & (K MT)
Table 62. South America mRNA Drug Sales by Type (K MT)
Table 63. South America mRNA Drug Market Size by Type (M USD)
Table 64. South America mRNA Drug Sales (K MT) by Type (2020-2033)
Table 65. South America mRNA Drug Market Size (M USD) by Type (2020-2033)
Table 66. South America mRNA Drug Sales by Application (K MT)
Table 67. South America mRNA Drug Market Size by Application (M USD)
Table 68. South America mRNA Drug Sales (K MT) by Application (2020-2033)
Table 69. South America mRNA Drug Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa mRNA Drug Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa mRNA Drug Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa mRNA Drug Sales by Type (K MT)
Table 73. Middle East and Africa mRNA Drug Market Size by Type (M USD)
Table 74. Middle East and Africa mRNA Drug Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa mRNA Drug Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa mRNA Drug Sales by Application (K MT)
Table 77. Middle East and Africa mRNA Drug Market Size by Application (M USD)
Table 78. Middle East and Africa mRNA Drug Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa mRNA Drug Market Size (M USD) by Application (2020-2033)
Table 80. Global mRNA Drug Production (K MT) by Region(2020-2025)
Table 81. Global mRNA Drug Revenue (US$ Million) by Region (2020-2025)
Table 82. Global mRNA Drug Revenue Market Share by Region (2020-2025)
Table 83. Global mRNA Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America mRNA Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe mRNA Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan mRNA Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China mRNA Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global mRNA Drug Sales by Type (K MT)
Table 89. Global mRNA Drug Market Size by Type (M USD)
Table 90. Global mRNA Drug Sales (K MT) by Type (2020-2033)
Table 91. Global mRNA Drug Sales Market Share by Type (2020-2033)
Table 92. Global mRNA Drug Market Size (M USD) by Type (2020-2033)
Table 93. Global mRNA Drug Market Size Share by Type (2020-2033)
Table 94. Global mRNA Drug Sales (K MT) by Application
Table 95. Global mRNA Drug Market Size by Application(M USD)
Table 96. Global mRNA Drug Sales by Application (2020-2033) & (K MT)
Table 97. Global mRNA Drug Sales Market Share by Application (2020-2033)
Table 98. Global mRNA Drug Market Size by Application (2020-2033) & (M USD)
Table 99. Global mRNA Drug Market Share by Application (2020-2033)
Table 100. Global mRNA Drug Sales Growth Rate by Application (2020-2033)
Table 101. Moderna Basic Information
Table 102. Moderna mRNA Drug Product Overview
Table 103. Moderna mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Moderna Business Overview
Table 105. Moderna SWOT Analysis
Table 106. Moderna Recent Developments
Table 107. Pfizer Basic Information
Table 108. Pfizer mRNA Drug Product Overview
Table 109. Pfizer mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Pfizer Business Overview
Table 111. Pfizer SWOT Analysis
Table 112. Pfizer Recent Developments
Table 113. Zydus Cadila Basic Information
Table 114. Zydus Cadila mRNA Drug Product Overview
Table 115. Zydus Cadila mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Zydus Cadila Business Overview
Table 117. Zydus Cadila SWOT Analysis
Table 118. Zydus Cadila Recent Developments
Table 119. Fosun Pharma Basic Information
Table 120. Fosun Pharma mRNA Drug Product Overview
Table 121. Fosun Pharma mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Fosun Pharma Business Overview
Table 123. Fosun Pharma Recent Developments
Table 124. CureVAC Basic Information
Table 125. CureVAC mRNA Drug Product Overview
Table 126. CureVAC mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. CureVAC Business Overview
Table 128. CureVAC Recent Developments
Table 129. Sri Lankan Microorganisms Basic Information
Table 130. Sri Lankan Microorganisms mRNA Drug Product Overview
Table 131. Sri Lankan Microorganisms mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Sri Lankan Microorganisms Business Overview
Table 133. Sri Lankan Microorganisms Recent Developments
Table 134. BioNtech Basic Information
Table 135. BioNtech mRNA Drug Product Overview
Table 136. BioNtech mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. BioNtech Business Overview
Table 138. BioNtech Recent Developments
Table 139. AstraZeneca Basic Information
Table 140. AstraZeneca mRNA Drug Product Overview
Table 141. AstraZeneca mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. AstraZeneca Business Overview
Table 143. AstraZeneca Recent Developments
Table 144. Janssen Basic Information
Table 145. Janssen mRNA Drug Product Overview
Table 146. Janssen mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Janssen Business Overview
Table 148. Janssen Recent Developments
List of Figures
Figure 1. Product Picture of mRNA Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Drug Market Size (M USD), 2024-2033
Figure 5. Global mRNA Drug Market Size (M USD) (2020-2033)
Figure 6. Global mRNA Drug Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global mRNA Drug Product Life Cycle
Figure 13. mRNA Drug Sales Share by Manufacturers in 2024
Figure 14. Global mRNA Drug Revenue Share by Manufacturers in 2024
Figure 15. mRNA Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market mRNA Drug Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by mRNA Drug Revenue in 2024
Figure 18. Industry Chain Map of mRNA Drug
Figure 19. Global mRNA Drug Market PEST Analysis
Figure 20. Global mRNA Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global mRNA Drug Market Size by Region
Figure 27. Global mRNA Drug Market Size Market Share by Region (2020-2033)
Figure 28. Global mRNA Drug Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America mRNA Drug Market Size (M USD) by Country
Figure 33. USA mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada mRNA Drug Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada mRNA Drug Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico mRNA Drug Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico mRNA Drug Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America mRNA Drug Market Size (M USD)by Type
Figure 40. North America mRNA Drug Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe mRNA Drug Market Size (M USD) by Country
Figure 45. Germany mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. mRNA Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe mRNA Drug Market Size (M USD) by Type
Figure 56. Europe mRNA Drug Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific mRNA Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific mRNA Drug Market Size (M USD) by Country
Figure 61. China mRNA Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China mRNA Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan mRNA Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan mRNA Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea mRNA Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea mRNA Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India mRNA Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India mRNA Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia mRNA Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia mRNA Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific mRNA Drug Market Size (M USD) by Type
Figure 72. Asia-Pacific mRNA Drug Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America mRNA Drug Market Size (M USD) by Country
Figure 77. Brazil mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America mRNA Drug Market Size (M USD) by Type
Figure 84. South America mRNA Drug Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa mRNA Drug Market Size (M USD) by Country
Figure 89. Saudi Arabia mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa mRNA Drug Market Size (M USD) by Type
Figure 100. Middle East and Africa mRNA Drug Market Size (M USD) by Application
Figure 101. Global mRNA Drug Production Market Share by Region (2020-2025)
Figure 102. North America mRNA Drug Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe mRNA Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan mRNA Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. China mRNA Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global mRNA Drug Market Size by Type (M USD)
Figure 108. Sales Market Share of mRNA Drug by Type (2020-2033)
Figure 109. Sales Market Share of mRNA Drug by Type in 2024
Figure 110. Market Size Share of mRNA Drug by Type (2020-2033)
Figure 111. Market Size Share of mRNA Drug by Type in 2024
Figure 112. Global mRNA Drug Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global mRNA Drug Market Size by Application(M USD)
Figure 115. Global mRNA Drug Market Share by Application
Figure 116. Global mRNA Drug Sales Market Share by Application (2020-2033)
Figure 117. Global mRNA Drug Sales Market Share by Application in 2024
Figure 118. Global mRNA Drug Market Share by Application (2020-2033)
Figure 119. Global mRNA Drug Market Share by Application in 2024
Figure 120. Global mRNA Drug Sales Growth Rate by Application (2020-2033)
1.1 Market Definition and Statistical Scope of mRNA Drug
1.2 Key Market Segments
1.2.1 mRNA Drug Segment by Type
1.2.2 mRNA Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL MRNA DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global mRNA Drug Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global mRNA Drug Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL MRNA DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global mRNA Drug Product Life Cycle
3.3 Global mRNA Drug Sales by Manufacturers (2020-2025)
3.4 Global mRNA Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 mRNA Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global mRNA Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers mRNA Drug Manufacturing Sites, Area Served, Product Type
3.8 mRNA Drug Market Competitive Situation and Trends
3.8.1 mRNA Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest mRNA Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MRNA DRUG INDUSTRY CHAIN ANALYSIS
4.1 mRNA Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRNA DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global mRNA Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to mRNA Drug Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL MRNA DRUG MARKET BY REGION
6.1 Global mRNA Drug Market Size by Region
6.1.1 Global mRNA Drug Market Size by Region
6.1.2 Global mRNA Drug Market Size Market Share by Region
6.2 Global mRNA Drug Sales by Region
6.2.1 Global mRNA Drug Sales by Region
6.2.2 Global mRNA Drug Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America mRNA Drug Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America mRNA Drug Market Size by Type
7.3 North America mRNA Drug Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe mRNA Drug Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe mRNA Drug Market Size by Type
8.3 Europe mRNA Drug Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific mRNA Drug Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific mRNA Drug Market Size by Type
9.3 Asia-Pacific mRNA Drug Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America mRNA Drug Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America mRNA Drug Market Size by Type
10.3 South America mRNA Drug Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa mRNA Drug Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa mRNA Drug Market Size by Type
11.3 Middle East and Africa mRNA Drug Market Size by Application
12 MRNA DRUG MARKET PRODUCTION BY REGION
12.1 Global Production of mRNA Drug by Region(2020-2025)
12.2 Global mRNA Drug Revenue Market Share by Region (2020-2025)
12.3 Global mRNA Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America mRNA Drug Production
12.4.1 North America mRNA Drug Production Growth Rate (2020-2025)
12.4.2 North America mRNA Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe mRNA Drug Production
12.5.1 Europe mRNA Drug Production Growth Rate (2020-2025)
12.5.2 Europe mRNA Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan mRNA Drug Production (2020-2025)
12.6.1 Japan mRNA Drug Production Growth Rate (2020-2025)
12.6.2 Japan mRNA Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China mRNA Drug Production (2020-2025)
12.7.1 China mRNA Drug Production Growth Rate (2020-2025)
12.7.2 China mRNA Drug Production, Revenue, Price and Gross Margin (2020-2025)
13 MRNA DRUG MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global mRNA Drug Sales Market Share by Type (2020-2033)
13.3 Global mRNA Drug Market Size Market Share by Type (2020-2033)
13.4 Global mRNA Drug Price by Type (2020-2033)
14 MRNA DRUG MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global mRNA Drug Market Sales by Application (2020-2033)
14.3 Global mRNA Drug Market Size (M USD) by Application (2020-2033)
14.4 Global mRNA Drug Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 Moderna
15.1.1 Moderna Basic Information
15.1.2 Moderna mRNA Drug Product Overview
15.1.3 Moderna mRNA Drug Product Market Performance
15.1.4 Moderna Business Overview
15.1.5 Moderna SWOT Analysis
15.1.6 Moderna Recent Developments
15.2 Pfizer
15.2.1 Pfizer Basic Information
15.2.2 Pfizer mRNA Drug Product Overview
15.2.3 Pfizer mRNA Drug Product Market Performance
15.2.4 Pfizer Business Overview
15.2.5 Pfizer SWOT Analysis
15.2.6 Pfizer Recent Developments
15.3 Zydus Cadila
15.3.1 Zydus Cadila Basic Information
15.3.2 Zydus Cadila mRNA Drug Product Overview
15.3.3 Zydus Cadila mRNA Drug Product Market Performance
15.3.4 Zydus Cadila Business Overview
15.3.5 Zydus Cadila SWOT Analysis
15.3.6 Zydus Cadila Recent Developments
15.4 Fosun Pharma
15.4.1 Fosun Pharma Basic Information
15.4.2 Fosun Pharma mRNA Drug Product Overview
15.4.3 Fosun Pharma mRNA Drug Product Market Performance
15.4.4 Fosun Pharma Business Overview
15.4.5 Fosun Pharma Recent Developments
15.5 CureVAC
15.5.1 CureVAC Basic Information
15.5.2 CureVAC mRNA Drug Product Overview
15.5.3 CureVAC mRNA Drug Product Market Performance
15.5.4 CureVAC Business Overview
15.5.5 CureVAC Recent Developments
15.6 Sri Lankan Microorganisms
15.6.1 Sri Lankan Microorganisms Basic Information
15.6.2 Sri Lankan Microorganisms mRNA Drug Product Overview
15.6.3 Sri Lankan Microorganisms mRNA Drug Product Market Performance
15.6.4 Sri Lankan Microorganisms Business Overview
15.6.5 Sri Lankan Microorganisms Recent Developments
15.7 BioNtech
15.7.1 BioNtech Basic Information
15.7.2 BioNtech mRNA Drug Product Overview
15.7.3 BioNtech mRNA Drug Product Market Performance
15.7.4 BioNtech Business Overview
15.7.5 BioNtech Recent Developments
15.8 AstraZeneca
15.8.1 AstraZeneca Basic Information
15.8.2 AstraZeneca mRNA Drug Product Overview
15.8.3 AstraZeneca mRNA Drug Product Market Performance
15.8.4 AstraZeneca Business Overview
15.8.5 AstraZeneca Recent Developments
15.9 Janssen
15.9.1 Janssen Basic Information
15.9.2 Janssen mRNA Drug Product Overview
15.9.3 Janssen mRNA Drug Product Market Performance
15.9.4 Janssen Business Overview
15.9.5 Janssen Recent Developments
16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global mRNA Drug Market Size by Type (M USD)
Table 4. Global mRNA Drug Market Size by Application (M USD)
Table 5. mRNA Drug Market Size Comparison by Region (M USD)
Table 6. Global mRNA Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global mRNA Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global mRNA Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global mRNA Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Drug as of 2024)
Table 11. Global Market mRNA Drug Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers mRNA Drug Manufacturing Sites and Area Served
Table 13. Manufacturers mRNA Drug Product Type
Table 14. Global mRNA Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. mRNA Drug Market Size Comparison by Region (M USD)
Table 26. Global mRNA Drug Market Size by Region (2020-2033) & (M USD)
Table 27. Global mRNA Drug Market Size Market Share by Region (2020-2033)
Table 28. Global mRNA Drug Sales by Region (2020-2033) & (K MT)
Table 29. Global mRNA Drug Sales Market Share by Region (2020-2033)
Table 30. North America mRNA Drug Market Size by Country (2020-2033) & (M USD)
Table 31. North America mRNA Drug Sales by Country (2020-2033) & (K MT)
Table 32. North America mRNA Drug Sales by Type (K MT)
Table 33. North America mRNA Drug Market Size by Type (M USD)
Table 34. North America mRNA Drug Sales (K MT) by Type (2020-2033)
Table 35. North America mRNA Drug Market Size (M USD) by Type (2020-2033)
Table 36. North America mRNA Drug Sales by Application (K MT)
Table 37. North America mRNA Drug Market Size by Application (M USD)
Table 38. North America mRNA Drug Sales (K MT) by Application (2020-2033)
Table 39. North America mRNA Drug Market Size (M USD) by Application (2020-2033)
Table 40. Europe mRNA Drug Market Size by Country (2020-2033) & (M USD)
Table 41. Europe mRNA Drug Sales by Country (2020-2033) & (K MT)
Table 42. Europe mRNA Drug Sales by Type (K MT)
Table 43. Europe mRNA Drug Market Size by Type (M USD)
Table 44. Europe mRNA Drug Sales (K MT) by Type (2020-2033)
Table 45. Europe mRNA Drug Market Size (M USD) by Type (2020-2033)
Table 46. Europe mRNA Drug Sales by Application (K MT)
Table 47. Europe mRNA Drug Market Size by Application (M USD)
Table 48. Europe mRNA Drug Sales (K MT) by Application (2020-2033)
Table 49. Europe mRNA Drug Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific mRNA Drug Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific mRNA Drug Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific mRNA Drug Sales by Type (K MT)
Table 53. Asia-Pacific mRNA Drug Market Size by Type (M USD)
Table 54. Asia-Pacific mRNA Drug Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific mRNA Drug Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific mRNA Drug Sales by Application (K MT)
Table 57. Asia-Pacific mRNA Drug Market Size by Application (M USD)
Table 58. Asia-Pacific mRNA Drug Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific mRNA Drug Market Size (M USD) by Application (2020-2025)
Table 60. South America mRNA Drug Market Size by Country (2020-2033) & (M USD)
Table 61. South America mRNA Drug Sales by Country (2020-2033) & (K MT)
Table 62. South America mRNA Drug Sales by Type (K MT)
Table 63. South America mRNA Drug Market Size by Type (M USD)
Table 64. South America mRNA Drug Sales (K MT) by Type (2020-2033)
Table 65. South America mRNA Drug Market Size (M USD) by Type (2020-2033)
Table 66. South America mRNA Drug Sales by Application (K MT)
Table 67. South America mRNA Drug Market Size by Application (M USD)
Table 68. South America mRNA Drug Sales (K MT) by Application (2020-2033)
Table 69. South America mRNA Drug Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa mRNA Drug Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa mRNA Drug Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa mRNA Drug Sales by Type (K MT)
Table 73. Middle East and Africa mRNA Drug Market Size by Type (M USD)
Table 74. Middle East and Africa mRNA Drug Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa mRNA Drug Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa mRNA Drug Sales by Application (K MT)
Table 77. Middle East and Africa mRNA Drug Market Size by Application (M USD)
Table 78. Middle East and Africa mRNA Drug Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa mRNA Drug Market Size (M USD) by Application (2020-2033)
Table 80. Global mRNA Drug Production (K MT) by Region(2020-2025)
Table 81. Global mRNA Drug Revenue (US$ Million) by Region (2020-2025)
Table 82. Global mRNA Drug Revenue Market Share by Region (2020-2025)
Table 83. Global mRNA Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America mRNA Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe mRNA Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan mRNA Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China mRNA Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global mRNA Drug Sales by Type (K MT)
Table 89. Global mRNA Drug Market Size by Type (M USD)
Table 90. Global mRNA Drug Sales (K MT) by Type (2020-2033)
Table 91. Global mRNA Drug Sales Market Share by Type (2020-2033)
Table 92. Global mRNA Drug Market Size (M USD) by Type (2020-2033)
Table 93. Global mRNA Drug Market Size Share by Type (2020-2033)
Table 94. Global mRNA Drug Sales (K MT) by Application
Table 95. Global mRNA Drug Market Size by Application(M USD)
Table 96. Global mRNA Drug Sales by Application (2020-2033) & (K MT)
Table 97. Global mRNA Drug Sales Market Share by Application (2020-2033)
Table 98. Global mRNA Drug Market Size by Application (2020-2033) & (M USD)
Table 99. Global mRNA Drug Market Share by Application (2020-2033)
Table 100. Global mRNA Drug Sales Growth Rate by Application (2020-2033)
Table 101. Moderna Basic Information
Table 102. Moderna mRNA Drug Product Overview
Table 103. Moderna mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Moderna Business Overview
Table 105. Moderna SWOT Analysis
Table 106. Moderna Recent Developments
Table 107. Pfizer Basic Information
Table 108. Pfizer mRNA Drug Product Overview
Table 109. Pfizer mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Pfizer Business Overview
Table 111. Pfizer SWOT Analysis
Table 112. Pfizer Recent Developments
Table 113. Zydus Cadila Basic Information
Table 114. Zydus Cadila mRNA Drug Product Overview
Table 115. Zydus Cadila mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Zydus Cadila Business Overview
Table 117. Zydus Cadila SWOT Analysis
Table 118. Zydus Cadila Recent Developments
Table 119. Fosun Pharma Basic Information
Table 120. Fosun Pharma mRNA Drug Product Overview
Table 121. Fosun Pharma mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Fosun Pharma Business Overview
Table 123. Fosun Pharma Recent Developments
Table 124. CureVAC Basic Information
Table 125. CureVAC mRNA Drug Product Overview
Table 126. CureVAC mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. CureVAC Business Overview
Table 128. CureVAC Recent Developments
Table 129. Sri Lankan Microorganisms Basic Information
Table 130. Sri Lankan Microorganisms mRNA Drug Product Overview
Table 131. Sri Lankan Microorganisms mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Sri Lankan Microorganisms Business Overview
Table 133. Sri Lankan Microorganisms Recent Developments
Table 134. BioNtech Basic Information
Table 135. BioNtech mRNA Drug Product Overview
Table 136. BioNtech mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. BioNtech Business Overview
Table 138. BioNtech Recent Developments
Table 139. AstraZeneca Basic Information
Table 140. AstraZeneca mRNA Drug Product Overview
Table 141. AstraZeneca mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. AstraZeneca Business Overview
Table 143. AstraZeneca Recent Developments
Table 144. Janssen Basic Information
Table 145. Janssen mRNA Drug Product Overview
Table 146. Janssen mRNA Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Janssen Business Overview
Table 148. Janssen Recent Developments
List of Figures
Figure 1. Product Picture of mRNA Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Drug Market Size (M USD), 2024-2033
Figure 5. Global mRNA Drug Market Size (M USD) (2020-2033)
Figure 6. Global mRNA Drug Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global mRNA Drug Product Life Cycle
Figure 13. mRNA Drug Sales Share by Manufacturers in 2024
Figure 14. Global mRNA Drug Revenue Share by Manufacturers in 2024
Figure 15. mRNA Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market mRNA Drug Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by mRNA Drug Revenue in 2024
Figure 18. Industry Chain Map of mRNA Drug
Figure 19. Global mRNA Drug Market PEST Analysis
Figure 20. Global mRNA Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global mRNA Drug Market Size by Region
Figure 27. Global mRNA Drug Market Size Market Share by Region (2020-2033)
Figure 28. Global mRNA Drug Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America mRNA Drug Market Size (M USD) by Country
Figure 33. USA mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada mRNA Drug Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada mRNA Drug Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico mRNA Drug Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico mRNA Drug Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America mRNA Drug Market Size (M USD)by Type
Figure 40. North America mRNA Drug Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe mRNA Drug Market Size (M USD) by Country
Figure 45. Germany mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. mRNA Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe mRNA Drug Market Size (M USD) by Type
Figure 56. Europe mRNA Drug Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific mRNA Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific mRNA Drug Market Size (M USD) by Country
Figure 61. China mRNA Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China mRNA Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan mRNA Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan mRNA Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea mRNA Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea mRNA Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India mRNA Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India mRNA Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia mRNA Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia mRNA Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific mRNA Drug Market Size (M USD) by Type
Figure 72. Asia-Pacific mRNA Drug Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America mRNA Drug Market Size (M USD) by Country
Figure 77. Brazil mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America mRNA Drug Market Size (M USD) by Type
Figure 84. South America mRNA Drug Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa mRNA Drug Market Size (M USD) by Country
Figure 89. Saudi Arabia mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa mRNA Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa mRNA Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa mRNA Drug Market Size (M USD) by Type
Figure 100. Middle East and Africa mRNA Drug Market Size (M USD) by Application
Figure 101. Global mRNA Drug Production Market Share by Region (2020-2025)
Figure 102. North America mRNA Drug Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe mRNA Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan mRNA Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. China mRNA Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global mRNA Drug Market Size by Type (M USD)
Figure 108. Sales Market Share of mRNA Drug by Type (2020-2033)
Figure 109. Sales Market Share of mRNA Drug by Type in 2024
Figure 110. Market Size Share of mRNA Drug by Type (2020-2033)
Figure 111. Market Size Share of mRNA Drug by Type in 2024
Figure 112. Global mRNA Drug Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global mRNA Drug Market Size by Application(M USD)
Figure 115. Global mRNA Drug Market Share by Application
Figure 116. Global mRNA Drug Sales Market Share by Application (2020-2033)
Figure 117. Global mRNA Drug Sales Market Share by Application in 2024
Figure 118. Global mRNA Drug Market Share by Application (2020-2033)
Figure 119. Global mRNA Drug Market Share by Application in 2024
Figure 120. Global mRNA Drug Sales Growth Rate by Application (2020-2033)